Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 67% of resolved cases
Marcia Stephens Noble works in Tech Center 1600 and Art Unit 1632. The data reflects 855 resolved cases and an allowance rate of 67.0%. This 67.0% rate provides a baseline for the probability of reaching an allowance during prosecution. The median days to allowance is 1165, which outlines the typical timeframe for successful applications. With 855 resolved cases, the statistical profile for this examiner is well-established.
The interview lift is 39.9%, which is a substantial figure for practitioners to consider. This 39.9% lift suggests that interviews are a highly effective strategy for increasing the 67.0% baseline allowance rate. Applicants should prioritize direct communication to take advantage of this 39.9% increase in success probability. The 1165 median days to allowance helps in managing client expectations regarding the total time to grant. This analysis of Art Unit 1632 is based on the 855 resolved cases available.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17722312 | VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS | Non-Final OA | The Regents of the University of California |
| 18740453 | DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY | Non-Final OA | President and Fellows of Harvard College |
| 18336001 | HUMAN PRIMARY MYELOFIBROSIS CELL STRAIN AND USE THEREOF | Final Rejection | ZHEJIANG UNIVERSITY |
| 18648678 | METHODS AND COMPOSITIONS TO ENHANCE THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN 10 | Non-Final OA | The Regents of the University of Colorado, a Body Corporate |
| 18276164 | Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor Cells | Non-Final OA | Baylor College of Medicine |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | Non-Final OA | UNIVERSITEIT GENT |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | Non-Final OA | FUJIFILM Cellular Dynamics, Inc. |
| 17883263 | ASSESSING RETINAL PIGMENT EPITHELIAL CELL POPULATIONS | Non-Final OA | CELL CURE NEUROSCIENCES LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy